Canada markets closed

Anagenics Limited (AN1.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.0080+0.0010 (+14.29%)
At close: 10:07AM AEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
10,196
9,113
9,235
5,816
7,381
Cost of Revenue
5,449
4,702
4,170
2,113
2,534
Gross Profit
4,748
4,412
5,065
3,704
4,847
Operating Expenses
Research Development
-
21.193
110.347
118.793
849.019
Selling General and Administrative
6,553
5,876
8,229
5,893
7,199
Total Operating Expenses
7,493
6,747
9,627
8,228
11,279
Operating Income or Loss
-2,746
-2,336
-4,562
-4,524
-6,432
Interest Expense
63.887
31.844
69.86
54.756
71.257
Total Other Income/Expenses Net
215.528
611.479
464.809
343.242
1,147
Income Before Tax
-2,580
-1,734
-3,644
-3,760
-4,818
Income Tax Expense
0.001
7.87
4.783
45.049
89.473
Income from Continuing Operations
-2,580
-1,742
-3,649
-3,805
-4,907
Net Income
-3,160
-2,667
-3,649
-3,387
-4,907
Net Income available to common shareholders
-3,160
-2,667
-3,649
-3,387
-4,907
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Basic Average Shares
265,950
265,950
211,374
142,533
105,584
Diluted Average Shares
265,950
265,950
211,374
142,533
105,584